PMID: 8940672Oct 1, 1996Paper

Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution

International Journal of STD & AIDS
U ClaessonA Siboulet

Abstract

Podophyllotoxin solution (0.5%) is licensed for use in the treatment of condylomata acuminata (genital warts) in men in a number of European countries. In some countries, approval also extends to treatment of genital warts in women. This controlled randomized prospective study evaluated the efficacy and safety of a cream formulation of podophyllotoxin at 2 concentrations (0.15% and 0.3%), using 0.5% podophyllotoxin solution as a reference treatment. Two separate studies were initiated, to assess the 3 treatment groups in (a) male patients, and (b) female patients. Statistical evaluation was based on a "response rate' calculated at each clinic visit. The mean "response rates' in the male patient study at 4 weeks were 75.1%, 79.0% and 85.6% in the 0.15% cream, 0.3% cream and 0.5% solution groups, respectively. The corresponding "response rates' for the female patient study were 86.2%, 92.6%, and 93.1%, respectively. The relapse rates for both male and female patients were 6.0% in the 0.15% cream group, 8.6% in the 0.3% cream group and 8.6% in the 0.5% solution group. The results show that there were no statistically significant differences between the 3 treatments with regard to both efficacy and safety. This was true for both th...Continue Reading

Citations

Nov 21, 2001·Sexually Transmitted Infections·G von Krogh, E Longstaff
Aug 7, 2003·Sexually Transmitted Infections·C J N LaceyUNKNOWN Perstop Pharma Genital Warts Clinical Trial Group
Jul 3, 1999·Comprehensive Therapy·D P Krowchuk
May 15, 2003·Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology·Uwe Wollina
Jan 6, 2001·Scandinavian Journal of Urology and Nephrology. Supplementum·G von Krogh, S Horenblas
May 16, 2012·Journal of the American Academy of Dermatology·Rachel H Gormley, Carrie L Kovarik
Feb 6, 2004·Dermatologic Therapy·Patricia T Ting, Marlene T Dytoc
Mar 14, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·C J N LaceyJ Ross
Mar 9, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Charles J N Lacey
Aug 11, 2004·Toxicon : Official Journal of the International Society on Toxinology·M GordalizaM A Gómez-Zurita
Sep 21, 2001·Best Practice & Research. Clinical Obstetrics & Gynaecology·C Sonnex, C J Lacey
Sep 9, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Hans Michael Ockenfels
Sep 9, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Hans Michael Ockenfels
Sep 29, 2004·Antiviral Research·Peter DrobniMagnus Evander
Oct 9, 2001·International Journal of STD & AIDS·G von KroghUNKNOWN European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Healt
Nov 3, 2016·Sexually Transmitted Infections·Ricardo Niklas WernerAlexander Nast
May 1, 2002·Current Opinion in Pulmonary Medicine·T Mark Doherty, Peter Andersen
Mar 30, 2007·Journal of Internal Medicine·D B Meya, K P W J McAdam
Nov 14, 2012·Memórias do Instituto Oswaldo Cruz·Daniele KuhleisMaria Lucia Rosa Rossetti
Aug 1, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·R GilsonJ Ross
Jul 21, 2020·Revista Internacional De Andrología·Bruno Jorge PereiraPedro Vendeira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of STD & AIDS
Christina StefanakiAndreas Katsambas
International Journal of STD & AIDS
G von KroghEuropean Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Healt
© 2021 Meta ULC. All rights reserved